SE8204549L - Spirotiazolidinyl-piperazin-derivat, forfarande for framstellning derav samt farmaceutiska preparat innehallande nemnda derivat - Google Patents

Spirotiazolidinyl-piperazin-derivat, forfarande for framstellning derav samt farmaceutiska preparat innehallande nemnda derivat

Info

Publication number
SE8204549L
SE8204549L SE8204549A SE8204549A SE8204549L SE 8204549 L SE8204549 L SE 8204549L SE 8204549 A SE8204549 A SE 8204549A SE 8204549 A SE8204549 A SE 8204549A SE 8204549 L SE8204549 L SE 8204549L
Authority
SE
Sweden
Prior art keywords
derivatives
spirotiazolidinyl
preparing
procedure
pharmaceutical preparations
Prior art date
Application number
SE8204549A
Other languages
English (en)
Other versions
SE453503B (sv
SE8204549D0 (sv
Inventor
Jr D L Temple
R E Yeager
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8204549D0 publication Critical patent/SE8204549D0/sv
Publication of SE8204549L publication Critical patent/SE8204549L/sv
Publication of SE453503B publication Critical patent/SE453503B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8204549A 1981-08-03 1982-08-02 Spirotiazolidinyl-piperazin-derivat, forfarande for framstellning derav samt farmaceutiska preparat innehallande nemnda derivat SE453503B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/289,351 US4456756A (en) 1981-08-03 1981-08-03 Spirothiazolidinyl piperazine derivatives

Publications (3)

Publication Number Publication Date
SE8204549D0 SE8204549D0 (sv) 1982-08-02
SE8204549L true SE8204549L (sv) 1983-02-04
SE453503B SE453503B (sv) 1988-02-08

Family

ID=23111156

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204549A SE453503B (sv) 1981-08-03 1982-08-02 Spirotiazolidinyl-piperazin-derivat, forfarande for framstellning derav samt farmaceutiska preparat innehallande nemnda derivat

Country Status (28)

Country Link
US (1) US4456756A (sv)
JP (1) JPS5838277A (sv)
KR (1) KR880001737B1 (sv)
AT (1) AT380477B (sv)
AU (1) AU555870B2 (sv)
BE (1) BE894021A (sv)
CA (1) CA1208642A (sv)
CH (1) CH655503B (sv)
DE (1) DE3228992A1 (sv)
DK (1) DK156219C (sv)
ES (2) ES8401763A1 (sv)
FI (1) FI76794C (sv)
FR (1) FR2510571B1 (sv)
GB (1) GB2105714B (sv)
GR (1) GR76171B (sv)
HU (1) HU191505B (sv)
IE (1) IE53613B1 (sv)
IL (1) IL66433A (sv)
IT (1) IT1149026B (sv)
LU (1) LU84315A1 (sv)
NL (1) NL8203035A (sv)
NZ (1) NZ201158A (sv)
OA (1) OA07171A (sv)
PH (1) PH18688A (sv)
PT (1) PT75365B (sv)
SE (1) SE453503B (sv)
YU (1) YU44073B (sv)
ZA (1) ZA825481B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61162278A (ja) * 1985-01-09 1986-07-22 Nippon Yakin Kogyo Co Ltd 冷却手段を具えたロ−ラ−電極を含む自走式シ−ム溶接機
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
EP0316723B1 (en) * 1987-11-20 1992-09-30 Hoechst-Roussel Pharmaceuticals Incorporated 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments
JPH0270878U (sv) * 1988-11-21 1990-05-30

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125835C (sv) * 1960-05-24
US3106552A (en) * 1960-07-19 1963-10-08 Geschickter Fund Med Res Nu-substituted azaspiranes and azaspirane-diones and processes for their preparation
US3200118A (en) * 1961-10-31 1965-08-10 Geschickter Fund Med Res Spirocyclic hydrazine imides
US3432499A (en) * 1965-04-02 1969-03-11 Geschickter Fund Med Res Trifluoromethylazaspiranes and azaspirane diones
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
EP0002978B1 (fr) * 1977-12-29 1982-10-06 Synthelabo Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique
AU521110B2 (en) * 1978-06-20 1982-03-18 Synthelabo Phenylpiperazine derivatives
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives

Also Published As

Publication number Publication date
FR2510571A1 (fr) 1983-02-04
NL8203035A (nl) 1983-03-01
KR880001737B1 (ko) 1988-09-10
DK343782A (da) 1983-02-04
ES526149A0 (es) 1985-04-16
FI76794B (fi) 1988-08-31
YU44073B (en) 1990-02-28
AT380477B (de) 1986-05-26
US4456756A (en) 1984-06-26
FI822666L (fi) 1983-02-04
BE894021A (fr) 1983-02-03
CH655503B (sv) 1986-04-30
NZ201158A (en) 1985-12-13
SE453503B (sv) 1988-02-08
GB2105714B (en) 1985-05-15
YU158582A (en) 1985-04-30
IE821851L (en) 1983-02-03
GB2105714A (en) 1983-03-30
IE53613B1 (en) 1988-12-21
DE3228992A1 (de) 1983-02-17
AU8597382A (en) 1983-02-10
IT8248901A0 (it) 1982-07-28
IL66433A (en) 1985-10-31
CA1208642A (en) 1986-07-29
OA07171A (fr) 1984-04-30
ES514263A0 (es) 1984-01-01
GR76171B (sv) 1984-08-03
ES8504185A1 (es) 1985-04-16
JPH039912B2 (sv) 1991-02-12
LU84315A1 (fr) 1983-06-07
DK156219C (da) 1989-12-04
ES8401763A1 (es) 1984-01-01
FI822666A0 (fi) 1982-07-30
SE8204549D0 (sv) 1982-08-02
FI76794C (sv) 1988-12-12
FR2510571B1 (fr) 1987-07-10
JPS5838277A (ja) 1983-03-05
IT1149026B (it) 1986-12-03
PT75365B (en) 1985-11-20
PT75365A (en) 1982-09-01
HU191505B (en) 1987-02-27
DK156219B (da) 1989-07-10
KR840001166A (ko) 1984-03-28
AU555870B2 (en) 1986-10-16
ATA299382A (de) 1985-10-15
ZA825481B (en) 1983-04-27
IL66433A0 (en) 1982-12-31
PH18688A (en) 1985-09-05

Similar Documents

Publication Publication Date Title
SE8204550D0 (sv) Tiazolidinylalkylen-piperazin-derivat, forfarande for framstellning derav samt farmaceutiska preparat innehallande nemnda derivat
NO924696D0 (no) Fremgangsmaate for fremstilling av oksazolidinon- og tiazolidinon-derivater
DK654589D0 (da) Heterocykliske derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
NO305657B1 (no) 4-substituerte piperidinderivater og farmas°ytisk preparat derav
NO905255D0 (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
DK13082A (da) Analogifremgangsmaade til fremstilling af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid-derivater
HU907065D0 (en) Process for manufacturing pharmaceutical preparative of transdermal action containing 2-amino-6-(n-propyl-amino)-4,5,6,7-tetrahydro-benzothiazole
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO912411D0 (no) Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO905008D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
ZA974984B (en) New substituted thiazolidine-2,4-dione derivatives, processes for the obtaining thereof, and pharmaceutical compositions containing them.
NL180587C (nl) Werkwijze voor het bereiden van 1-((4,4-diarylbutyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-onen, en werkwijze voor het bereiden of vervaardigen van deze verbindingen bevattende farmaceutische preparaten.
SE8204549L (sv) Spirotiazolidinyl-piperazin-derivat, forfarande for framstellning derav samt farmaceutiska preparat innehallande nemnda derivat
DK122391A (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
SE8105341L (sv) N-((4-(3-substituerad pyridyl)piperazino)alkyl)azaspirodekandioner
NO167204C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diacylderivater av 4-(trialkylbenzyl)-piperazinylforbindelser.
NO155137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 2-(4-piperidyl)-1-(4-kinolyl)-etanon.
NO892543D0 (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
NO880474D0 (no) Alkylsubstituerte n-benzopyranyllaktaner, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater paa basis av disse forbindelser.
NO159532C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 1-(4-kinolyl)-2-(4-piperidyl)-etanol eller1-(4-kinolyl)-3-(4-piperidyl)-propanol.
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
NO912979D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenederivater.
NL193192B (nl) Oxicamderivaat, farmaceutisch preparaat dat het derivaat bevat en werkwijze voor het bereiden van oxicamderivaten.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8204549-3

Effective date: 19920306

Format of ref document f/p: F